Evergreen Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.62M | Sell |
11,864
-1,106
| -9% | -$306K | 0.05% | 295 |
|
|
2026
Q1 | $3.83M | Buy |
12,970
+727
| +6% | +$216K | 0.08% | 229 |
|
|
2025
Q4 | $3.34M | Buy |
12,243
+404
| +3% | +$110K | 0.07% | 235 |
|
|
2025
Q3 | $3.2M | Buy |
11,839
+538
| +5% | +$146K | 0.08% | 223 |
|
|
2025
Q2 | $3.11M | Buy |
11,301
+988
| +10% | +$269K | 0.09% | 210 |
|
|
2025
Q1 | $2.74M | Buy |
10,313
+173
| +2% | +$42.7K | 0.09% | 212 |
|
|
2024
Q4 | $2.35M | Buy |
10,140
+11
| +0.1% | +$2.53K | 0.08% | 232 |
|
|
2024
Q3 | $2.23M | Sell |
10,129
-168
| -2% | -$34.8K | 0.08% | 237 |
|
|
2024
Q2 | $2.02M | Buy |
10,297
+423
| +4% | +$87.4K | 0.07% | 235 |
|
|
2024
Q1 | $2.13M | Buy |
9,874
+189
| +2% | +$39.7K | 0.08% | 223 |
|
|
2023
Q4 | $2.04M | Sell |
9,685
-43
| -0.4% | -$9.18K | 0.08% | 227 |
|
|
2023
Q3 | $1.95M | Buy |
9,728
+173
| +2% | +$34.4K | 0.09% | 220 |
|
|
2023
Q2 | $1.77M | Buy |
9,555
+963
| +11% | +$178K | 0.07% | 229 |
|
|
2023
Q1 | $1.65M | Buy |
8,592
+972
| +13% | +$176K | 0.07% | 232 |
|
|
2022
Q4 | $1.31M | Sell |
7,620
-402
| -5% | -$69.9K | 0.06% | 252 |
|
|
2022
Q3 | $1.42M | Buy |
8,022
+784
| +11% | +$155K | 0.07% | 229 |
|
|
2022
Q2 | $1.48M | Sell |
7,238
-110
| -1% | -$23.3K | 0.08% | 220 |
|
|
2022
Q1 | $1.75M | Buy |
7,348
+125
| +2% | +$29.4K | 0.07% | 232 |
|
|
2021
Q4 | $1.65M | Buy |
7,223
+174
| +2% | +$38.3K | 0.07% | 240 |
|
|
2021
Q3 | $1.36M | Sell |
7,049
-4
| -0.1% | -$810 | 0.06% | 249 |
|
|
2021
Q2 | $1.5M | Buy |
7,053
+238
| +3% | +$50.3K | 0.07% | 227 |
|
|
2021
Q1 | $1.39M | Buy |
6,815
+245
| +4% | +$48.3K | 0.07% | 225 |
|
|
2020
Q4 | $1.2M | Buy |
6,570
+522
| +9% | +$88.8K | 0.07% | 209 |
|
|
2020
Q3 | $1.01M | Sell |
6,048
-31
| -0.5% | -$5.22K | 0.07% | 201 |
|
|
2020
Q2 | $988K | Buy |
6,079
+58
| +1% | +$10.4K | 0.07% | 192 |
|
|
2020
Q1 | $1.04M | Sell |
6,021
-237
| -4% | -$47.2K | 0.1% | 166 |
|
|
2019
Q4 | $1.26M | Buy |
6,258
+13
| +0.2% | +$2.67K | 0.1% | 152 |
|
|
2019
Q3 | $1.32M | Buy |
6,245
+12
| +0.2% | +$2.51K | 0.12% | 140 |
|
|
2019
Q2 | $1.21M | Buy |
6,233
+2
| +0% | +$369 | 0.12% | 144 |
|
|
2019
Q1 | $1.02M | Sell |
6,231
-91
| -1% | -$16.1K | 0.1% | 152 |
|
|
2018
Q4 | $1.19M | Buy |
6,322
+58
| +0.9% | +$10.7K | 0.12% | 141 |
|
|
2018
Q3 | $1.07M | Buy |
6,264
+21
| +0.3% | +$3.54K | 0.09% | 151 |
|
|
2018
Q2 | $1.02M | Buy |
+6,243
| New | +$1.02M | 0.1% | 148 |
|
Other funds holding CME
Evergreen Capital Management's CME Position: Q2 2026 in Review
Evergreen Capital Management reduced its CME Group (CME) stake by 8.5% in Q2 2026, selling an estimated $306K and leaving 11,864 shares worth $2.62M. The position accounts for 0.05% of the portfolio, ranked #295.
Evergreen Capital Management first reported a position in CME in Q2 2018 and has held it in 33 quarters since. The position peaked at $3.83M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Evergreen Capital Management held 11,864 shares of CME Group worth $2.62M as of Q2 2026.
- Evergreen Capital Management sold 1,106 CME Group shares in Q2 2026, an estimated $306K.
- CME Group made up 0.05% of Evergreen Capital Management's portfolio in Q2 2026, its #295 holding.
- Evergreen Capital Management first reported a position in CME Group in Q2 2018 and has held it in 33 quarters since.
- Evergreen Capital Management's CME Group position peaked at $3.83M in Q1 2026.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.